EichorEICHOR
Location: Yerevan Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Yerevan

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study
Phase N/A · S. Malayan Eye Center · Sanoculis Ltd · NCT06577857
Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery
Phase 3 · Yeolyan Hematology and Oncology Centre · Octapharma · NCT04918173
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal
Phase N/A · Hematology Center after Prof. Yeolyan · International Extranodal Lymphoma Study Group (IELSG) · NCT05700149
Establishment of a Tissue Registry for Hepatocellular Carcinoma Specimens
Phase N/A · Nikomed Medical Center · Nikomed Medical Center · NCT05935189
Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Co
Phase 2 · Center of Medical Genetics and Primary Health Care LLC · R-Pharm International, LLC · NCT05190991
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
Phase N/A · Hematology Center named after prof. R. Yeolyan · Immune Oncology Research Institute · NCT05430971
EnDOvascular Therapy for Late WiNdow IschEmic Stroke Patients Selected bY AutoMatic Plain ComputErized Tomography
NA · Erebouni Medical Center · Santiago Ortega Gutierrez · NCT07001852
Chronic Coronary Syndrome Snapshot Study
Phase N/A · Erebouni Medical Center · European Society of Cardiology · NCT06748924
ColoSeal™ ICD System Safety and Feasibility Study
NA · National Center of Oncology after V.A. Fanarjian · Averto Medical, Inc. · NCT06402188
A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to
Phase 3 · Site 101001 · mAbxience Research S.L. · NCT06687369
Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impa
Phase 1 · Erebuni Medical Center · Taiho Oncology, Inc. · NCT04953897
A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®
Phase 1 · "Tonus-Les" LLC · Berlin-Chemie AG Menarini Group · NCT07156916
Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids
Phase 1/Phase 2 · Yeolyan Hematology. , and Oncology Center - · Shionogi · NCT05588323
Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Tre
Phase 3 · Octapharma Research Site · Octapharma · NCT06361537
Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
Phase N/A · Hematology Center after Prof.R.H. Yeolyan · Santé Arménie French-Armenian Research Center · NCT05904301
Cardiac Angiosarcoma International Registry
Phase N/A · Yeolyan Hematology and Oncology Center · Immune Oncology Research Institute · NCT06715579
CAYA Cancer Retrospective Cohort Study
Phase N/A · Yeolyan Center for Cancer and Blood Disorders · Resonance, Inc. · NCT07246213
PVEK Corneal Implant For Treatment of Corneal Edema
Phase 1 · Ophthalmological Center After S.V.Malayan · Precise Bio · NCT07325097
Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Im
Phase 1 · Erebuni Medical Center · Taiho Oncology, Inc. · NCT04953910
Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries
Phase N/A · Real World Real People · Médecins du Monde · NCT06395129
Clinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 in Pregnancy and Pre-Eclampsia
NA · N2 · Withings · NCT07595016
A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
Phase 3 · "ARABKIR" Joint Medical Center & Institute of Child and Adol · Genexine, Inc. · NCT06466785
Clinical Epidemiology in Contemporary Patients With Myelofibrosis.
Phase N/A · Hematology Center after Prof.R.H. Yeolyan · FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS · NCT06533813
CAYA Cancer Prospective Cohort Study
Phase N/A · Yeolyan Center for Cancer and Blood Disorders · Resonance, Inc. · NCT07632014
Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania
EARLY_Phase 1 · National Institute for Infectious Diseases · Médecins du Monde · NCT06159504
Invobenitug Also Known as Procizumab (PCZ; AK1967) in Critical Cardiovascular Care
Phase 1/Phase 2 · Yerevan medical scientific center · 4TEEN4 Pharmaceuticals GmbH · NCT06832722
Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001)
Phase 2 · Hematology Center named after prof. R. Yeolyan · Immune Oncology Research Institute · NCT05891821
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non
Phase 2 · Ophthalmological Center After S.V. Malayan · Galimedix Therapeutics Inc · NCT06659549
Rare Embryonal Tumors of the Central Nervous System: International Registry
Phase N/A · Hematology Center named after prof. R. Yeolyan · Immune Oncology Research Institute · NCT05711992
Look up another city
Look up another condition